Skin care composition and method of making a skin care composition

ABSTRACT

A method for managing a skin care system. The skin care system includes circuitry to receive skin information from a user. The circuitry determines treatable skin conditions based on the skin information. The skin care system generates severity information and cosmetic formulation compatibility information based on the treatable skin conditions. The skin care system is further able to virtually display user-specific compatible cosmetic formulations based on at least one parameter associated with the severity information and cosmetic formulation compatibility.

PRIORITY AND RELATED APPLICATIONS

This patent application claims benefit of priority to U.S. patentapplication Ser. No. 15/477,965 filed on Apr. 3, 2017, entitled “SKINCARE COMPOSITION AND METHOD OF MAKING A SKIN CARE COMPOSITION,” thedisclosure of which is incorporated by reference as if fully rewrittenherein.

FIELD OF TECHNOLOGY

The present disclosure is directed to systems, devices, and methodsincluding a skin care composition and a treatment skin conditions. Morespecifically, the present disclosure is directed to systems, devices,and methods including a skin care composition that has targeted activeingredients for treating target skin conditions and methods for creatingcustomized skin care compositions.

BACKGROUND

Personalized skin care systems are desirable for consumers to provide askin care composition that meets the skin care needs of the individualconsumer.

Examples of personalized product lines include MaCrèmeSurMesure by Dr.Pierre Ricaud, Codage Paris, Customized TCM by Yue Sai, and prescriptionpersonalized serums (Re-Plasty) by Helena Rubinstein.

Helena Rubinstein uses a skinprofiler, a cutaneous analysis device thatgenerates quantitative data to analyze a variety of skin attributes todiagnose consumers in-store and provide them with a personalizedprescription product consisting of one universal serum base and singledose of concentrate. Helena Rubenstein products only consist of onesingle dose of concentrate containing actives that seek to address allskincare needs. In addition, the Helena Rubenstein product is a serum(aqueous based) product with water-soluble actives. The HelenaRubinstein skinprofiler measures elasticity, pigmentation, and textureof the skin and prescribes concentrate based on these results only.

Codage Paris has a custom-made skincare product line. Consumers use awebsite diagnostic tool in which they answer 23 questions that weredeveloped by different specialists (including dermatologists,pharmacists, and nutritionists). Based on the results, Codage selectsand formulates a composition in their existing line and sends consumersa final product within a week. The Codage Paris system does not includea base composition with personalized boosters. Codage Paris is a serum(aqueous based) product with water soluble actives. A diagnostic toolutilized for Codage is an online survey which automatically ‘prescribes’a final product based on provided answers. The Codage Product provides afinal pre-prepared formula for the consumer, which is sent directly fromstore to consumer, wherein no mixing is required.

MaCrèmeSurMesure by Dr. Pierre Ricaud similarly uses an onlinediagnostic tool in which consumers are given a questionnaire on theircurrent skin and lifestyle. Based on the answers they provide, thewebsite provides them with a cream base and combination of three activeconcentrates. Each “concentrate” for the MaCrèmeSurMesure only containsa single active ingredient. Typical “concentrates” for theMaCrèmeSurMesure products consist solely of pure extracts (100% activeextract of chufa tubers, for example) and do not provide formulations.The MaCrèmeSurMesure product is aqueous based (water based moisturizinggel texture) and booster “concentrates” are water soluble extracts inaqueous form. The consumer is sent a kit with their products and mixesat home with a small mixing tool provided, which is not easilyco-soluble. MaCrèmeSurMesure uses an online questionnaire to diagnoseconsumer.

Yue Sai is a Customized TCM Beauty Solution Ultimate Refining Serum thatincludes in-store formulations in China. The tailoring of theformulations were limited and included only aqueous based compositions.

There remains a need to provide an effective, skin care composition andmethod for treating skin that is customized to specific, individualcustomer target skin compositions and that is stable and efficacious.

BRIEF SUMMARY

In an exemplary embodiment, a method for managing a skin care systemincluding generating, a user interface including one or more visualrepresentations of a categorical skin condition, each of the visualrepresentations corresponding to a severity score for the categoricalskin condition. The method additionally includes generating, one or moreseverity scores responsive to one or more inputs indicative of auser-selected categorical skin condition. The method additionallyincludes generating a skin care regimen information including a cosmeticformulation based on one or more inputs associated with a severity scoreand one or more inputs indicative of a compatibility informationassociated with one or more cosmetic formulations.

In an embodiment, a skin care management system, including circuitryconfigured to extract one or more significant features corresponding toone or more skin conditions captured in a plurality of digital images.In an embodiment, the skin care system includes circuitry configured togenerate severity information and cosmetic formulation compatibilityinformation based on one or more inputs associated with extracting theone more significant features. In an embodiment, the skin care systemincludes circuitry configured to virtually display user-specificcompatible cosmetic formulation information based on at least oneparameter associated with severity information and the cosmeticformulation compatibility information.

Other features and advantages of the present disclosure will be apparentfrom the following more detailed description of the preferred embodimentwhich illustrates, by way of example, the principles of the disclosure.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates a cosmetic dispensing system, according to anembodiment of the present disclosure.

FIG. 2 a shows a method, according to an embodiment of the presentdisclosure.

FIG. 3 a shows a method, according to an alternate embodiment of thepresent disclosure.

FIG. 4 shows a visual skin guide, according to an embodiment of thepresent disclosure.

FIG. 5 is a block diagram of a skin care system including aninput/output device, a cosmetic blender, and a skin care managementsystem, including a microprocessor and a memory, according to anembodiment of the present disclosure.

FIG. 6 is a flow chart of a method of managing a skin care systemaccording to an embodiment of the present disclosure.

FIG. 7 is a flow chart of a method of managing a skin care systemaccording to an embodiment of the present disclosure.

FIG. 8 is a flow chart of a method of managing a skin care systemaccording to an embodiment of the present disclosure.

FIG. 9 is a flow chart of a method of managing a skin care systemaccording to an embodiment of the present disclosure.

FIG. 10 illustrates a cosmetic dispensing system including the mixingmodule according to an embodiment with the hinged lid removed.

FIG. 11 illustrates a cosmetic dispensing system including thedispensing module according to an embodiment with the hinged lid andouter housing removed.

FIG. 12 illustrates a cosmetic dispensing system including thedispensing actuator according to an embodiment with the hinged lid andouter housing removed.

FIG. 13 shows a block diagram of the hardware included in the apparatusaccording to an embodiment.

FIG. 14 shows an overall skin care system which implements the cosmeticdispensing system according to an embodiment.

Wherever possible, the same reference numbers will be used throughoutthe drawings to represent the same parts.

DETAILED DESCRIPTION

All numbers expressing quantities of ingredients and/or reactionconditions are to be understood as being modified in all instances bythe term “about”, unless otherwise indicated.

The method and system, according to the present disclosure, includes amethod wherein a comprehensive skin condition diagnosis practice thatproduces a targeted and efficacious product. The skin conditions of aconsumer are analyzed either automatically, using a digital system ormanually, for treatment with a skin care product. In one embodiment,consumers are provided with a questionnaire or shown representativephotos of common skin conditions, wherein the consumers/patients provideinformation correlating to their individual skin care needs. In oneembodiment, a skin care professional fills out a questionnaire basedupon information from or about the consumer. Based on the correlation tothe skin information obtained, the consumers are provided with aformulation including a base composition and boosters having actives,which form a stable composition having efficacious concentrations ofactive ingredients corresponding to the desired skin treatment.

Cosmetic Dispensing System

FIG. 1 shows a cosmetic dispensing system 100, according to anembodiment of the present disclosure. The cosmetic dispensing system 100includes a dispensing module 101 and a mixing module 103. A hinged lid102 is hingeably attached to the outer housing 104. Dispensing module101 provides a plurality of dispensing dosing receptacles 105 mounted ona carousel 107 that is rotatably driven to align the dispensing dosingreceptacles 105 with a receiving receptacle 109 positioned in areceiving portion 111 of the cosmetic dispensing system 100. Thecarousel 107 and dispensing dosing receptacles 105 are driven such that,when a formula is provided, the dispensing dosing receptacles 105 areindependently and sequentially aligned with the receiving portion 111 toprovide ingredients from the dispensing dosing receptacles 105 to thereceiving receptacle 109 to provide a skin care composition having adesired ingredient combination according to the formulationcorresponding to the consumer skin condition and the compatibilityprofile between the base compositions and booster compositions in theformulation.

Method

FIG. 2 shows a method 200, according to the present disclosure. Method200 includes obtaining skin information corresponding to a consumer(step 201). The method 200 further includes generating a skin conditioncorresponding to the skin information (step 203). Exemplary skinconditions for the first skin condition may include but are not limitedto skin requiring displaying some level of oiliness/dryness of the skin,requiring exfoliation (e.g., sensitivity), requiringlightening/whitening, and/or requiring anti-aging. One example mayinclude a very dry skin condition and the utilization of base withoutdrying components but containing nourishing attributes. Furthermore, avery oily skin condition may utilize a hydroalcoholic base compositionto help resolve this skin concern. The skin condition determined mayalso include a comparison of the numerical value, grade or other valueindicator for the severity of the skin condition to determine which aresuitable for treatment. In one particularly suitable embodiment, thecorrelation may include a consultation with a skin care professional,who may assist the consumer in determining the priority in which skinconditions may be present and/or desirably treated or may assist incomparing the severity score in determining the target skin conditions.For example, the skin condition may include, in one embodiment, aseverity score to determine specific exfoliants, lightening agents,and/or anti-aging agents that correspond to the severity of the skincondition. The ingredients selected are dependent upon the skincondition. In one embodiment, the base composition is determined by thepatient's skin type. For example, in another embodiment, the skincondition may include, a severity score to determine dosing or grade ofexfoliating agents, lightening agents, and/or anti-aging agents thatcorrespond to the severity of the skin condition or the priority ofwhich the skin conditions should be treated. In one embodiment, the skincondition that is first utilized to select an ingredient includes a skincondition that corresponds to the skin condition of the consumer thathas the greatest severity. In another embodiment, the skin conditionutilized to select an ingredient may include a skin condition thatrelates to a condition that the consumer or skin care professionalprioritizes as a greater need for treatment.

The skin condition may determine scores for categories of concern, suchas, for example: pigmentation concern, sensitivity, complexion,wrinkles, texture, hydration, or oily/dry skin. In one particularlysuitable embodiment, consultation from a skin care professional may beutilized. The skin care consultant may provide direction relating to theconsumer's current regimen, skin type, skin concerns and lifestyle. Toassess top skin concerns, diagnostic tools which may include, but arenot limited to, a combination of a special prescription card (ranking ofconcerns) and reference pictures (skin atlas) are utilized. In addition,the skin information and the skin condition may be determined utilizingautomated systems. For example, different devices for performing theskin diagnosis are readily understood in the art, such as the LancomeDiagnos ABS, HR Skinscope, Biotherm Bluesmart, Kiehl's Skinprofiler V.0,CA Dermanalyzer, and the Vichy Vichyconsult.

In one embodiment, determining the skin information corresponding to aconsumer is done via a visual display shown to the consumer. FIG. 4shows an exemplary visual skin guide for obtaining skin information.Although FIG. 4 shows an example of visual skin guide, the presentinvention is not so limited and may include other types of visualdisplays and/or may provide skin information that correlates to otherskin conditions. Other suitable types of visual displays include, butare not limited to, books, brochures and pamphlets including, but notlimited to, pictures and/or description of skin condition and scale,clinical pictures, and photos taken with instrumental devices. Thepictures and/or photos may include representations of skin conditionsfor panelists of different ethnicities and skin types. The visualdisplay will correspond to the varying ethnicities and skin types. Aselection of a specific visual display is made to consumer's ethnicityand/or skin types. The visual skin guide 400 is a device includingvisual representations 401, including, but not limited to, images,pictorial representations or similar visual devices that provideinformation regarding categorical skin conditions. In one embodiment, asshown in FIG. 4, each of the visual skin guides includes a plurality ofvisual representations of a categorical skin condition. In thisembodiment, each of the visual representations corresponds to a severityscore 403 for the categorical skin condition on the visual skin guide.As noted above, the severity score may be utilized to determine whichtype of ingredient may be added to the formulation or which grade ofingredient may be added to the formulation.

For example, as shown in FIG. 4, the visual representations may includephotographs showing a particular category of skin condition of thecategorical skin conditions including, but not limited to, skinbrightness, aging, visibility of pores, skin texture, skin redness, skinfirmness, skin tone evenness, or undesired skin pigmentation with ascore that corresponds to severity. The severity score 403 may be anumerical value, grade value or any other suitable scoring that permitsthe determination of skin conditions. In one embodiment, the visual skinguide 400 includes four photographs of a particular skin conditionscored numerically, for example, from 1 to 3 or from 1 to 4 or from 1 to5 or from 1 to 10 or from 1 to 20 or from 1 to 100. In an alternateembodiment, the score includes a presence (i.e., yes) or absence (i.e.,no) of a condition. The consumer, in one embodiment, may self-select thescore that most closely corresponds to the skin condition that theconsumer believes is present. This score is utilized in determination ofthe skin condition utilized to determine the corresponding ingredient.

In one embodiment, an information processing apparatus is configured tooutput a series of questions to the user to collect information aboutthe consumer for collecting skin information. However, alternativeembodiments are also available in which the user enters informationdirectly into appropriate fields displayed on the information processingapparatus without being prompted by displayed questions in order toinput the information into the information processing apparatus.

For example, the information processing apparatus may collectbiographical information about the patient/consumer, such as name, age,skin tone, or any other information which may be used to generate aprofile of the patient/consumer. For collecting skin information of thepatient/consumer, a series of questions or fields are presented to theuser to generate preferences on types of skin conditions thepatient/consumer would like to address through the composition dispensedby the apparatus 100.

Referring again to FIG. 2, method 200 further includes selecting aningredient corresponding to the skin condition (step 205). Theingredient includes a base composition or a booster composition thatcorresponds to the skin condition. For example, a booster containingalpha-hydroxy acid (e.g., lactic acid) active ingredients could beselected for a consumer with a skin conditioning denoting a highseverity of skin dullness, while a booster containing4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) andhydroxyethyl urea could be selected for a consumer with a lower severityof skin dullness. In another instance, a booster containingC-beta-D-xylopyranoside-2-hydroxypropane (Pro-Xylane) could be selectedfor a selected for a consumer with a skin conditioning denoting a lowseverity of visible wrinkles. The selection of ingredients includesconsideration of the previously selected ingredients and thecompatibility profile of the previously selected ingredient. Inaddition, the selection of ingredient includes correlation of the skincondition to a specific ingredient or type of ingredient (e.g.,exfoliating agents, whitening agents and/or anti-aging agents).Alternatively, the selection of ingredient may include a prioritizationbased upon other factors, such as consumer preference, or order oftreatment from a skin care professional. In the case of the ingredient,the primary consideration of the selection of the ingredient is the skincondition, and its severity score or priority. In correlating the skincondition, the severity or priority includes a determination of thegrade of ingredient. Grade, as utilized herein, includes an ingredientdifferent efficacy for a particular condition. For example, a secondgrade exfoliation agent provides greater exfoliation than the firstgrade exfoliation agent. Likewise, such first and second grades arepresent for whitening and anti-aging agents. Additional considerationsin determining the ingredient may further include the consumer tolerancefor certain ingredients. For example, certain ingredients may result inskin effects that are undesirable to the consumer. For example, aningredient with a higher grade than the individual could handle due tolimited pre-exposure or high potency can cause the skin to show signs ofredness or swelling. A booster containing the active ingredient retinolmay be appropriate for a consumer displaying a high severity of visiblesigns of skin aging, while the same ingredient may be too harsh for theskin of a consumer with a low severity of visible signs of skin aging,or for a consumer who has sensitivity to the ingredient Retinol. For aconsumer for whom Retinol is too harsh, using the ingredient may resultin redness, peeling, or skin sensitivity. As such, a selection of afirst grade ingredient may be prioritized over the selection of a secondgrade ingredient for an ingredient that produces undesirable skineffects to the consumer.

Referring again to FIG. 2, after the ingredient is determined, acompatibility profile is determined corresponding to the previouslyselected ingredients (step 207). The compatibility profile includes aninclusion or exclusion of additional ingredients to the formulation.That is, the compatibility profile provides acceptable combinations ofbooster composition and base composition combinations made with thepreviously selected ingredients that forms stable and efficacious skincare compositions. Compatibility for use in the compatibility profileincludes, but is not limited to, combinations of base compositions andbooster compositions that have 1) stability, including phasecompatibility and solubility, 2) desirable pH, including a pH that doesnot result in esterification or similar incompatibility effects and 3)efficacy, including combinations of base compositions and boostercompositions that retain the efficacy to provide the desired treatmentfor the skin condition determined in the formulation. “Stable”,“Stability” and grammatical variations thereof, indicate a macroscopichomogeneous substance that doesn't have variation in texture or varyingphases physically noticeable. In addition, microscopically the emulsionof the composition has the appearance of being homogeneous with thedroplets and no dynamic changes in the microscope image. Examples ofcompatibility that result in a stable efficacious skin care compositioninclude ingredients that have compatible pH, such that the combinationof the ingredients do not provide esterification, crystallization,separation, and precipitation or other incompatible effects. Inaddition, compatibility may include ingredients that have compatiblesolubility that result in a stable emulsion, wherein the ingredients donot readily break into phases. In addition, compatibility may includeingredients that retain efficacy of individual ingredients when combinedwith the other ingredients remain present in the formula over timeperiods and exposures to varying temperature. For example, as anincompatible combination, a hydroalcoholic base is not compatible withretinol (as a second grade anti-aging agent) because the combinationresults in an incompatible pH and results in separation of phases. Inanother example, glycolic acid, lactic acid and sodium phytate (as asecond grade exfoliation agent) are not compatible with the aqueousemulsion because the combination results in crystallization of thebooster components. In another example, glycolic acid, lactic acid andsodium phytate (as a second grade exfoliation agent) are not compatiblewith tranexamic acid and urea (as a second grade whitening agent)because of a pH incompatibility.

Method 200 further includes repeating the generating skin conditions,selecting the ingredient and generating the compatibility profile untila sufficient number of ingredients are selected to provide a formulation(step 209). The sufficient number of ingredients includes a number ofingredients that address the skin concerns of the consumer based uponthe skin information or include a number of ingredients corresponding toa skin care plan or regiment. For example, the skin care plan mayinclude ingredients for treatment of the top three or four skinconditions, which correspond to three for four ingredients. However, thepresent disclosure is not so limited, as any number of skin conditionsmay be treated. In one embodiment, the skin care plan would correspondto at least three ingredients wherein the ingredients include a basecomposition and at least two booster compositions, the base compositionand the booster compositions corresponding to skin conditions of theconsumer for treatment.

Once the desired number of ingredients are selected, formulationincluding the ingredients is generated (step 211). In one embodiment,the formulation includes a base composition and at least two boostercompositions. In another embodiment, the formulation includes a basecomposition and three booster compositions. Once the formulation isgenerated, the formulation, including the selected ingredients, isdispensed. The dispensing may be done manually or via an automateddispenser. After or during the dispensing the dispensed formulation maybe mixed. Mixing may be mixed manually or automatically during or afterthe dispensing. For example, in one embodiment, as show in FIG. 1, themixing may be provided by the mixing module 103 of cosmetic dispensingsystem 100. In this embodiment, the receiving receptacle 109 is filledby the dispensing module 101 and then inserted into the mixing module103, wherein the receiving receptacle is mixed to provide a stable,homogeneous mixture.

FIG. 3 shows an exemplary method 300, according to the presentdisclosure. Method 300 includes obtaining skin information correspondingto a consumer (step 301). The method 300 further includes generating afirst skin condition corresponding to the skin information (step 303).The first skin condition is obtained as shown and described above withrespect to FIG. 2.

Method 300 further includes selecting a first ingredient correspondingto the first skin condition (step 305). The first ingredient includes abase composition or a booster composition that corresponds to the firstskin condition.

After the first ingredient is determined, a first compatibility profileis determined corresponding to the previously selected ingredients (step307). The first compatibility profile includes an inclusion or exclusionof additional ingredients to the formulation. That is, the compatibilityprofile provides acceptable combinations of booster composition and basecomposition combinations made with the first ingredient that formsstable and efficacious skin care compositions.

Referring again to FIG. 3, method 300 further includes generating asecond skin condition corresponding to the skin information (step 309).The second skin condition also preferably corresponds to the first skincondition. As noted above with respect to the skin condition, the secondskin condition may include a severity or priority corresponding to theskin information or particular concerns of the consumer, whetherdetermined automatically with the assistance of diagnostic tools or viaa manual technique utilizing questionnaires or visual guides. Likewise,a skin care professional may assist or determine the skin care conditionand/or the severity or priority of the skin condition as it relates toan ingredient to treat the skin condition. For example, the second skincondition may include a skin condition that the consumer or a skin careprofessional with the skin information determines to be the second mostsevere skin condition for treatment. Likewise, the second skin conditionmay include a skin condition that the consumer or a skin careprofessional with the skin information determines to be the skincondition that has the second highest priority for treatment.

Method 300 further includes selecting a second ingredient correspondingto the second skin condition (step 311). The selection of a secondingredient includes consideration of the previous selected ingredientsand the compatibility profile of the previously selected ingredient.That is, the second ingredient selected includes a base composition or abooster composition that corresponds to the second skin condition thatis not the first ingredient. In addition, the selection of a secondingredient includes correlation of the skin condition, including aprioritization. In correlating the skin condition to the secondingredient, the severity or priority includes a determination of thegrade of ingredient. Accordingly, a second ingredient is selected, whichincludes a first or second grade of ingredient.

After the second ingredient is determined, method 300 further includesgenerating a second compatibility profile corresponding to the secondingredient and the first ingredient (step 313). Like the firstcompatibility profile, the second compatibility profile includes aninclusion or exclusion of additional ingredients to the formulation.That is, the second compatibility profile provides acceptablecombinations of booster composition and base composition combinationsmade with the first ingredient and the second ingredient that formstable and efficacious skin care compositions.

Referring again to FIG. 3, method 300 further includes generating athird skin condition corresponding to the skin information (step 315).The third skin condition also preferably corresponds to the first skincondition and the second skin condition. As noted above with respect tothe first condition, the third skin condition may include a severity orpriority corresponding to the skin information or particular concerns ofthe consumer, whether determined automatically with the assistance ofdiagnostic tools or via a manual technique utilizing questionnaires orvisual guides. Likewise, a skin care professional may assist ordetermine the skin care condition and/or the severity or priority of theskin condition as it relates to an ingredient to treat the skincondition. For example, the third skin condition may include a skincondition that the consumer or a skin care professional with the skininformation determines to be the third most severe skin condition fortreatment. Likewise, the third skin condition may include a skincondition that the consumer or a skin care professional with the skininformation determines to be the skin condition that has the thirdhighest priority for treatment.

Method 300 further includes selecting a third ingredient correspondingto the third skin condition (step 317). The selection of a thirdingredient includes consideration of the previously selected ingredientsand the compatibility profile of the previously selected ingredient.That is, the third ingredient includes a base composition or a boostercomposition that corresponds to the third skin condition that is not thefirst ingredient or the second ingredient. In addition, the selection ofa third ingredient includes correlation of the skin condition, includinga prioritization. In correlating the skin condition to the secondingredient, the severity or priority includes a determination of thegrade of ingredient. Accordingly, a third ingredient is selected, whichincludes a first or second grade of ingredient.

After the third ingredient is determined, method 300 further includesgenerating a third compatibility profile corresponding to the thirdingredient, the second ingredient and the first ingredient (step 319).Like the first compatibility profile and the second compatibilityprofile, the third compatibility profile includes an inclusion orexclusion of additional ingredients to the formulation. That is, thethird compatibility profile provides acceptable combinations of boostercomposition and base composition combinations made with the firstingredient, the second ingredient and the third ingredient that formstable and efficacious skin care compositions.

Referring again to FIG. 3, method 300 further includes generating afourth skin condition corresponding to the skin information (step 321).The fourth skin condition also preferably corresponds to the first skincondition, the second skin condition and the third skin condition. Asnoted above with respect to the first condition, the fourth skincondition may include a severity or priority corresponding to the skininformation or particular concerns of the consumer, whether determinedautomatically with the assistance of diagnostic tools or via a manualtechnique utilizing questionnaires or visual guides. Likewise, a skincare professional may assist or determine the skin care condition and/orthe severity or priority of the skin condition as it relates to aningredient to treat the skin condition. For example, the fourth skincondition may include a skin condition that the consumer or a skin careprofessional with the skin information determines to be the fourth mostsevere skin condition for treatment. Likewise, the third skin conditionmay include a skin condition that the consumer or a skin careprofessional with the skin information determines to be the skincondition that has the fourth highest priority for treatment.

Method 300 further includes selecting a fourth ingredient correspondingto the fourth skin condition (step 317). The fourth ingredient includesa base composition or a booster composition that corresponds to thefourth skin condition that is not the first ingredient, the secondingredient or the third ingredient.

A formulation including the first ingredient, the second ingredient, thethird ingredient, and the fourth ingredient is generated (step 325). Theformulation includes a first ingredient, a second ingredient, a thirdingredient, and a fourth ingredient that corresponds to a basecomposition and three booster compositions. Once the formulation isgenerated and communicated, the first ingredient, the second ingredient,the third ingredient, and fourth ingredient are dispensed with acosmetic dispensing system. The dispensing may be done manually or viaan automated dispenser. In addition, after or during the dispensing theformulation may be mixed. The mixing may be mixed manually orautomatically during or after the dispensing. For example, in oneembodiment, as show in FIG. 1, the mixing may be provided by the mixingmodule 103 of cosmetic dispensing system 100.

In one embodiment, a process or algorithm performed by the circuitry ofan information processing apparatus for selecting the ingredients anddetermining the compatibility profile.

While the above has been described with respect to a first, second,third and fourth ingredient, other numbers of ingredients may beutilized, wherein additional skin conditions and additionalcompatibility profiles for determination of the formulation. Forexample, the first, second and third ingredients may correspond to abase composition and two booster compositions. Likewise, the first,second, third and fourth ingredients may include a fifth ingredient thatincludes a base composition and four booster compositions.

Formulation Ingredients

The formulation ingredients, according to the present disclosure,include ingredients selected from a base composition and at least twoboosters that correspond to the skin condition. In one embodiment, theformulation ingredients include a first ingredient, a second ingredient,a third ingredient and a fourth ingredient that correspond to a basecomposition and three booster compositions. In this embodiment, each ofthe first ingredient, the second ingredient, the third ingredient andthe fourth ingredient are independently selected from a basecomposition, which is one of an aqueous alcohol composition or anaqueous emulsion or a booster composition selected from the groupconsisting of a first grade exfoliating agent; a second gradeexfoliating agent, the second grade exfoliating agent providing greaterexfoliating than the first grade exfoliating agent; a first gradewhitening agent; a second grade whitening agent, the second gradewhitening agent providing greater whitening than the first gradewhitening agent; a first grade anti-aging agent; and a second gradeanti-aging agent, the second grade anti-aging agent providing greateranti-aging effects than the first grade anti-aging agent. The skin carecomposition formed from the formulation is stable and has efficaciousconcentrations of active ingredients corresponding to skin conditions ofa consumer. Each of the ingredients is preferably added from a boosteror base reservoir. In one embodiment, as shown in FIG. 1, boostercompositions and base compositions are contained in dispensing dosingreceptacles 105.

Exfoliation Booster Composition

In one embodiment, the ingredient selected may be an ingredient thatprovides exfoliation to improve skin appearance. As noted above, theselection of the ingredient may include a response to the consumer'sskin condition, the previously selected ingredients, the compatibilityprofile of the already selected ingredients, and the identity of thepreviously selected ingredients. Active ingredients corresponding toexfoliation include one or more actives that provide exfoliation of theskin. The exfoliation booster composition includes a first gradeexfoliation agent or a second grade exfoliation agent. The second gradeexfoliation agent provides greater exfoliation than the first gradeexfoliation agent. In the formulation and the selection of theindividual ingredients, the first grade exfoliation agent and the secondgrade exfoliation agent are not the same.

For example, in one embodiment, the actives corresponding to aningredient corresponding to a first grade exfoliation agent or a secondgrade exfoliation agent include one or more of glycolic acid, lacticacid, sodium phytate, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid(HEPES), hydroxyethyl urea, salicylic acid, citric acid, capryloylsalicylic acid, and other components that provide improvement to skinappearance, and combinations thereof. Efficacious concentrations of theingredients include concentration of active ingredients sufficientlyhigh to provide exfoliation. For example, efficacious concentrations offrom 1 wt % to about 15 wt % of glycolic acid, lactic acid, and sodiumphytate; from 0.5 wt % to about 5 wt %4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; from 2 wt % to about10 wt % hydroxyethyl urea; from 0.05 wt % to about 0.04 wt % salicylicacid, from 1 wt % to about 15 wt % citric acid; and from 0.01 wt % toabout 0.5 wt % capryloyl salicylic acid. In one embodiment, the activeingredients in a booster composition corresponding to the first gradeexfoliation agent include 6%4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid and 5.45%hydroxyethyl urea by weight of the skin care composition. In oneembodiment, the active ingredients in a booster compositioncorresponding to the second grade exfoliation agent include 6.7%glycolic acid, 3.3% lactic acid and 1.7% sodium phytate by weight of theskin care composition.

Whitening Booster Composition

In one embodiment, the ingredient selected may be an ingredient thatprovides skin whiteness. As noted above, the selection of the ingredientmay include a response to the consumer's skin condition, the previouslyselected ingredients, the compatibility profile of the already selectedingredients and the identity of the previously selected ingredients.Active ingredients corresponding to skin whiteness include one or moreactives that provide improvement to skin whiteness. The whiteningbooster composition includes a first grade whitening agent or a secondgrade whitening agent. The second grade whitening agent provides greaterwhitening than the first grade whitening agent. In the formulation andthe selection of the individual ingredients, the first grade whiteningagent and the second grade whitening agent are not the same.

For example, in one embodiment, the actives corresponding to aningredient corresponding to a first grade whitening agent or a secondgrade whitening agent include one or more of niacinamide, kojic acid,licorice extract, mulberry extract, tranexamic acid, urea, phenylethylresorcinol, ascorbic acid, and other components that provide improvementto skin whiteness, any other suitable soluble/dispersible targetedactive ingredient, and combinations thereof. Efficacious concentrationsof the ingredients include concentration of active ingredientssufficiently high to provide whitening. For example, efficaciousconcentrations of from 0.01 wt % to about 2 wt % of licorice extract;from 0.001 wt % to about 0.5 wt % mulberry extract; from 0.25 wt % toabout 10 wt % niacinamide; from 0.5 wt % to about 5 wt % koiic acid;from 0.01 wt % to about 1 wt % phenylethyl resorcinol; from about 0.1 wt% to about 4 wt % tranexamic acid; and from about 1 wt % to about 15 wt% ascorbic acid. In one embodiment, the active ingredients in the firstgrade whitening agent include 0.1% licorice extract; and 0.0025%mulberry extract, by weight of the skin care composition. In oneembodiment, the active ingredients in the second grade whitening agentinclude 3% niacinamide and 1% kojic acid by weight of the skin carecomposition. In one embodiment, the active ingredients in the secondgrade whitening agent include 0.5% phenylethyl resorcinol by weight ofthe skin care composition.

Anti-Aging Booster Composition

In one embodiment, the ingredient selected may be an ingredient thatprovides anti-aging. As noted above, the selection of the ingredient mayinclude a response to the consumer's skin condition, the previouslyselected ingredients, the compatibility profile of the already selectedingredients and the identity of the previously selected ingredients.Active ingredients corresponding to anti-aging include one or moreactives that provide improvement to skin appearance. The whiteningbooster composition includes a first grade anti-aging agent or a secondgrade anti-aging agent. The second grade anti-aging agent providesgreater anti-aging effects than the first grade anti-aging agent. In theformulation and the selection of the individual ingredients, the firstgrade anti-aging agent and the second grade anti-aging agent are not thesame.

For example, in one embodiment, the actives corresponding to aningredient corresponding to a first grade anti-aging agent or a secondgrade anti-aging agent include one or more ofC-beta-D-xylopyranoside-2-hydroxypropane (Pro-Xylane), retinol,peptides, caffeine, and other components that provide improvement toskin texture, any other suitable soluble/dispersible targeted activeingredient, and combinations thereof. Efficacious concentrations of theingredients include concentration of active ingredients sufficientlyhigh to provide anti-aging. For example, efficacious concentrations offrom 0.5 wt % to about 10 wt % ofC-beta-D-xylopyranoside-2-hydroxypropane; from 0.1 wt % to about 1.1retinol; from 0.5 wt % to about 10 wt % ascorbic acid; from 0.1 wt % toabout 1 wt % hyaluronic acid; from 0.01 wt % to about 1 wt % peptides;and from 0.1 wt % to about 1 wt % caffeine. In one embodiment, theactive ingredients in the first grade anti-aging agent include 3.5%C-beta-D-xylopyranoside-2-hydroxypropane, by weight of the skin carecomposition. In one embodiment, the active ingredients in the secondgrade anti-aging agent include 0.1% or 0.3% or 0.5% or 1.0% retinol, byweight of the anti-aging booster composition.

Booster Additives

The booster compositions noted above may further include additionaladditives. For example, the booster compositions may include humectants,such as glycol and glycerin, soothing ingredients, essential oils,Vitamin E, emollients or other ingredients for skin enhancement,solubilization or other beneficial or efficacious purpose.

In one embodiment, the booster compositions are contained in dispensingdosing receptacles 105 (see FIG. 1). The concentrations of theingredients for the booster ingredients (i.e., the exfoliating agents,the whitening agents and the anti-aging agents) in the dispensing dosingreceptacles 105 is preferably at or near the solubility limits of theindividual ingredients.

Base Composition

In addition to the plurality of booster compositions, base compositionsare also provided.

Aqueous Alcohol Base Composition

One base composition suitable for use in the skin care compositionincludes an aqueous alcohol base composition. The aqueous compositionincludes an aqueous composition, comprising, consisting essentially ofor consisting of an alcohol, such as ethanol or denatured alcohol. Inone embodiment, the base composition includes an aqueous alcohol basecomposition comprising about 35 wt % alcohol, balance water.

Aqueous Emulsion Base Composition

One base composition suitable for use in the skin care compositionincludes an aqueous emulsion base composition. The aqueous emulsion basecomposition includes an aqueous composition, comprising, consistingessentially of or consisting of an emulsifier, such as polyacrylatecrosspolymer-6. In one embodiment, the base composition includes anaqueous emulsion base composition comprising about 0.6 wt % polyacrylatecrosspolymer-6. In another embodiment, the base composition includes anaqueous emulsion base composition comprising the following composition:

TABLE 1 Concentration Concentration (% by wt of (% by wt of Name basecomposition) base composition) disodium EDTA 0.1 0.05-0.2  fattycompound 2 0.5-3  polymer 1 0.15 0.1-0.3 polymer 2 0.5 0.1-1  polymer 30.6 0.05-1.2  preservative 0.7 0.1-1.5 silicon 2 0.5-2.5 solvent 1 3 1-4solvent 2 4 1-5 solvent 3 3 0.5-4.5 solvent 4 0.3 0.05-1   surfactant0.5 0.1-1  vitamin 0.5 0.01-1   water 82.65 QS

The base compositions may include components suitable for providing skincare benefits, such as moisturization, protection of skin barrier, orother skin benefit.

In one embodiment, the base compositions are contained in dispensingdosing receptacles 105 (see FIG. 1). The concentration of theingredients for the base compositions in the dispensing dosingreceptacles 105 is preferably at the above indicated concentrations,wherein the base compositions include ranges of ingredients that permitdilution of the booster compositions to their efficaciousconcentrations, while maintaining the benefits of the boostercomposition.

Auxiliaries

In an embodiment, the composition of the disclosure may also containadjuvants that are common in cosmetics, such as humectants, preservingagents, antioxidants, complexing agents, solvents, fragrances,bactericides, odor absorbers, vitamins, moisturizers, self-tanningcompounds, and other active agents. The amounts of these variousadjuvants are those conventionally used in the field underconsideration, for example, from 0.01% to 20% of the total weight of thecomposition. In one embodiment, the additives or adjuvants would beadded to the booster formulations to functionalize them for specifictargeted treatments/needs.

Of course, a person skilled in the art will take care to choose this orthese optional additional compounds so that the advantageous propertiesintrinsically attached to the composition, in accordance with thedisclosure, are not, or not substantially, detrimentally affected by theenvisaged addition or additions.

Needless to say, a person skilled in the art will take care to selectthis or of these optional additional compound(s), and/or the amountthereof, such that the advantageous properties of the composition,according to the disclosure, are not, or are not substantially,adversely affected by the envisaged addition.

The present disclosure includes a method and system wherein acomprehensive target skin condition diagnosis practice with a targetedand efficacious product formulated and delivered to the user. In oneembodiment, a skin diagnosis/questionnaire, using visual aids, iscompleted to provide targeted skin care system to address the individualuser's needs. The users are shown representative images of common skinconditions, wherein the users view the visual aids and correlate thevisual aids with their individual skin care needs. Based on thecorrelation to the target skin conditions, the users get a customizedcosmetic formulation having a base oil composition and at least twoselected active booster compositions. In another embodiment, a digitalimage of a region of skin is analyzed to determine the individual user'sskin care needs. An embodiment of a skin care system 500 is shown inFIG. 5.

In the example of FIG. 5, the skin care system 500 includes one or moreinput/output devices 510 configured to display information to a user andreceive input from the user, one or more cosmetic dispensing systems 520configured to dispense and/or mix a cosmetic formulation, and a skincare management system 530, coupled to the one or more input/outputdevices 510 and the one or more cosmetic dispensing systems 520, andincluding a microprocessor and a memory.

The skin care management system 530, is communicatively coupled to theone or more input/output devices 510 and to the one or more cosmeticdispensing systems 520. The skin care management system 530, may bewirelessly connected to the input/output devices 510 and the cosmeticdispensing systems 520 wirelessly (e.g., Bluetooth, internet, fiberoptic, radio, and combinations thereof). In another embodiment, the skincare management system 530, may be connected to the input/output devices510 and the cosmetic dispensing systems 520 via electrical links (e.g.,wires). The skin care management system 530, may include, for example, amicrocontroller (the microcontroller having an electronic processor,memory, and input/output components on a single chip or within a singlehousing). Alternatively, the skin care management system may includeseparately configured components. The skin care management system 530,may also be implemented using other components or combinations ofcomponents including, for example, a digital signal processor (DSP), anapplication specific integrated circuit (ASIC), a field programmablearray (FPGA), or other circuitry. Depending on the desiredconfiguration, the processor may include one or more levels of caching,such as a level cache memory, one or more processor caches, andregisters. The example processor core may include an arithmetic logicunit (ALU), a floating point unit (FPU), or any combination thereof. Theskin care management system 530, may also include a user interface, acommunication interface, and other computer implemented devices forperforming features not defined herein. In some examples, an interfacebus for facilitating communication between various interface devices,computing implemented devices, and one or more peripheral interfaces tothe microprocessor may be provided.

In an embodiment, a skin-care-management system includes circuitryconfigured to extract one or more significant features corresponding toone or more skin conditions captured in a plurality of digital images.Non-limiting examples of significant features corresponding to one ormore skin conditions include pigmentation concern, sensitivity,complexion, wrinkles, texture, hydration, or oily/dry skin, which maycorrespond to skin requiring exfoliation, skin requiring whitening orskin requiring anti-aging treatment.

In an embodiment, circuitry includes, among other things, one or morecomputing devices such as a processor (e.g., a microprocessor, a quantumprocessor, qubit processor, etc.), a central processing unit (CPU), adigital signal processor (DSP), an application-specific integratedcircuit (ASIC), a field programmable gate array (FPGA), and the like, orany combinations thereof, and can include discrete digital or analogcircuit elements or electronics, or combinations thereof. In anembodiment, circuitry includes one or more ASICs having a plurality ofpredefined logic components. In an embodiment, circuitry includes one ormore FPGAs, each having a plurality of programmable logic components.

In an embodiment, circuitry includes one or more electric circuits,printed circuits, flexible circuits, electrical conductors, electrodes,cavity resonators, conducting traces, ceramic patterned electrodes,electro-mechanical components, transducers, and the like.

In an embodiment, circuitry includes one or more components operablycoupled (e.g., communicatively, electromagnetically, magnetically,ultrasonically, optically, inductively, electrically, capacitivelycoupled, wirelessly coupled, and the like) to each other. In anembodiment, circuitry includes one or more remotely located components.In an embodiment, remotely located components are operably coupled, forexample, via wireless communication. In an embodiment, remotely locatedcomponents are operably coupled, for example, via one or morecommunication modules, receivers, transmitters, transceivers, and thelike.

In an embodiment, circuitry includes memory that, for example, storesinstructions or information. Non-limiting examples of memory includevolatile memory (e.g., Random Access Memory (RAM), Dynamic Random AccessMemory (DRAM), and the like), non-volatile memory (e.g., Read-OnlyMemory (ROM), Electrically Erasable Programmable Read-Only Memory(EEPROM), Compact Disc Read-Only Memory (CD-ROM), and the like),persistent memory, and the like. Further non-limiting examples of memoryinclude Erasable Programmable Read-Only Memory (EPROM), flash memory,and the like. In an embodiment, memory is coupled to, for example, oneor more computing devices by one or more instructions, information, orpower buses.

In an embodiment, circuitry includes one or more computer-readable mediadrives, interface sockets, Universal Serial Bus (USB) ports, memory cardslots, and the like, and one or more input/output components such as,for example, a graphical user interface, a display, a keyboard, akeypad, a trackball, a joystick, a touch-screen, a mouse, a switch, adial, and the like, and any other peripheral device. In an embodiment,circuitry includes one or more user input/output components that areoperably coupled to at least one computing device configured to control(electrical, electromechanical, software-implemented,firmware-implemented, or other control, or combinations thereof) atleast one parameter associated with, for example, determining one ormore tissue thermal properties responsive to detected shifts in turn-ONvoltage.

In an embodiment, circuitry includes a computer-readable media drive ormemory slot that is configured to accept signal-bearing medium (e.g.,computer-readable memory media, computer-readable recording media, andthe like). In an embodiment, a program for causing a system to executeany of the disclosed methods can be stored on, for example, acomputer-readable recording medium, a signal-bearing medium, and thelike. Non-limiting examples of signal-bearing media include a recordabletype medium such as a magnetic tape, floppy disk, a hard disk drive, aCompact Disc (CD), a Digital Video Disk (DVD), Blu-Ray Disc, a digitaltape, a computer memory, and the like, as well as transmission typemedium such as a digital or an analog communication medium (e.g., afiber optic cable, a waveguide, a wired communications link, a wirelesscommunication link (e.g., receiver, transmitter, transceiver,transmission logic, reception logic, etc.). Further non-limitingexamples of signal-bearing media include, but are not limited to,DVD-ROM, DVD-RAM, DVD+RW, DVD-RW, DVD-R, DVD+R, CD-ROM, Super Audio CD,CD-R, CD+R, CD+RW, CD-RW, Video Compact Discs, Super Video Discs, flashmemory, magnetic tape, magneto-optic disk, MINIDISC, non-volatile memorycard, EEPROM, optical disk, optical storage, RAM, ROM, system memory,web server, and the like.

In an embodiment, circuitry includes acoustic transducers,electroacoustic transducers, electrochemical transducers,electromagnetic transducers, electromechanical transducers,electrostatic transducers, photoelectric transducers, radio-acoustictransducers, thermoelectric transducers, ultrasonic transducers, and thelike.

In an embodiment, circuitry includes electrical circuitry operablycoupled with a transducer (e.g., an actuator, a motor, a piezoelectriccrystal, a Micro Electro Mechanical System (MEMS), etc.) In anembodiment, circuitry includes electrical circuitry having at least onediscrete electrical circuit, electrical circuitry having at least oneintegrated circuit, or electrical circuitry having at least oneapplication specific integrated circuit. In an embodiment, circuitryincludes electrical circuitry forming a general purpose computing deviceconfigured by a computer program (e.g., a general purpose computerconfigured by a computer program which at least partially carries outprocesses and/or devices described herein, or a microprocessorconfigured by a computer program which at least partially carries outprocesses and/or devices described herein), electrical circuitry forminga memory device (e.g., forms of memory (e.g., random access, flash, readonly, etc.)), electrical circuitry forming a communications device(e.g., a modem, communications switch, optical-electrical equipment,etc.), and/or any non-electrical analog thereto, such as optical orother analogs.

In an embodiment, the skin care system 500 includes circuitry configuredto generate severity information and cosmetic formulation compatibilityinformation based on one or more inputs associated with extracting theone more significant features. Severity information is utilized todetermine dosing or grade of exfoliating agents, lightening agents,and/or anti-aging agents that correspond to the severity of the skincondition or the priority of which the skin conditions should betreated. In one embodiment, the skin condition includes a skin conditionthat corresponds to the skin condition of the consumer that has thegreatest severity. Non-limiting examples of severity information includelevel of pigmentation, the level of wrinkles on the skin of theconsumer/patient.

The compatibility profile includes an inclusion or exclusion ofadditional ingredients to the formulation. The compatibility profileincludes, but is not limited to, combinations of base compositions andbooster compositions that have 1) stability, including phasecompatibility and solubility, 2) desirable pH, including a pH that doesnot result in esterification or similar incompatibility effects and 3)efficacy, including combinations of base compositions and boostercompositions that retain the efficacy to provide the desired treatmentfor the skin condition determined in the formulation.

In an embodiment, the skin care system additionally includes circuitryconfigured to virtually display user-specific compatible cosmeticformulation information based on at least one parameter associated withseverity information and the cosmetic formulation compatibilityinformation. For example, during operation, a user interacts with anapplication to enter user-specific skin conditions and levels ofingredient tolerance, and the application displays options forcombinations of ingredients which are chemical compatible and meet theuser-specific conditions. More specifically, for example, duringoperation, a user interacts with the tablet application to answerquestions regarding personal levels of skin pigmentation, complexion,smoothness, wrinkles, sensitivities, ingredient tolerance, andhydration. The system then uses the user-specific skin-conditioninformation (i.e., skin information) to produce a recommendedcombination of ingredients which specifically target the user's levelsand sensitivities, while also taking into account each time the chemicalcompatibilities between the ingredients to only recommend a stableformulation. The application displays these compatible cosmeticformulations to the user on the application. The user then selects fromthese personalized options which they prefer.

In the example of FIG. 5, a memory of the skin care management system530 stores computer-readable instructions that, when executed by theelectronic processor of the skin care management system 530, cause theskin care management system 530, and more particularly the electronicprocessor, to perform or control the performance of various functions ormethods attributed to the skin care management system 530 herein (e.g.,receive user input, receive uploaded data, determine a cosmeticformulation, determine a compatibility profile, determine severityscores, determine target skin conditions, communicate with a medicalprofessional, establish secure communications, output information to theuser, and combinations thereof). The memory may include any transitory,non-transitory, volatile, non-volatile, magnetic, optical, or electricalmedia, such as random access memory (RAM), read-only memory (ROM),non-volatile RAM (NVRAM), electrically erasable programmable ROM(EEPROM), flash memory, or any other digital or analog media. Thefunctions attributed to the skin care management system 530 herein maybe embodied as software, firmware, hardware, or any combination thereof.

In an example, the skin care management system 530 and the one or moreinput/output devices 510 (e.g., digital camera, cellular phone, tablet,personal digital assistant (PDA), a laptop, a computer, a wearabledevice, keyboard, sensors, and combinations thereof) may be embedded ina computing device and the one or more cosmetic dispensing systems 520may be configured to communicate with the skin care management system530. In this example, the one or more cosmetic dispensing systems 520are configured to have wireless and/or wired communication with the skincare management system 530. For example, the one or more cosmeticdispensing systems 520 and the skin care management system 530 may beconfigured to communication via a network. In another example, skin caremanagement system 530, may be remotely located on a server and may beconfigured to receive data from an external input/output device (e.g., adigital camera, a cellular phone, a tablet, a personal digital assistant(PDA), a laptop, a computer, a wearable device, a sensor), as well as,send data to a computing device as human readable format. The computingdevice may function as the device to display information to the userand/or receive input from the user. The computing device may include acellular phone, a tablet, a personal digital assistant (PDA), a laptop,a computer, a wearable device, or other suitable computing device. Thenetwork may be a cloud computing network, a server, a wireless areanetwork (WAN), a local area network (LAN), an in-vehicle network, orother suitable network.

The skin care management system 530, is configured to receive input fromthe user including skin information data associated with one or moreskin conditions. The skin care management system 530, then determinesone or more skin conditions based on the skin information. The skin caremanagement system 530, then determines a severity score for each of theone or more skin conditions based on the skin information data. Based onthe severity scores, the skin care management system 530 determines oneor more targeted skin conditions and a cosmetic formulation to treat thetargeted skin conditions. The skin care management system 530,additionally determines a compatibility score based on theinteroperability of the components of the cosmetic formulation.

FIG. 6 is a flowchart of a method 600 of managing a skin care system500. At block 602, the skin care management system 630 causes theinput/output device (1/O device) 510 to display one or more visual skinguides to the user, each of the visual skin guides may include one ormore visual representations of a categorical skin condition, each of thevisual representations corresponding to a severity score for thecategorical skin condition of the one or more visual skin care guides.In some embodiments, the visual skin care guide may include images ofone or more skin conditions. In some embodiments, the visual skin guidemay include a questionnaire with or without associated images.Alternatively, embodiments are also available in which the user entersinformation directly into appropriate fields displayed on theinformation processing apparatus without being prompted by displayedquestions in order to input the information into the informationprocessing apparatus. At block 604, the skin care management system 530receives from the input/output device 510 one or inputs from the userincluding skin information corresponding to one or more visualrepresentations of the categorical skin condition of the one or morevisual skin guides. At block 606, the skin care management system 530determines one or more skin conditions based on the skin informationinputs from the user. At block 608, the skin care management system 430determines one or more severity scores based on the one or more skinconditions. At block 610, the skin care management system 530 determinesa primary skin condition based on the severity scores. At block 612, theskin care management system 530 selects a first ingredient based on theone or more severity scores. At block 614, the skin care managementsystem 530 generates a compatibility profile based on the firstingredient. At block 616, the skin care management system 530 determinesone or more secondary skin conditions based on the one or more severityscores. At block 618, the skin care management system 530 selects anadditional ingredient based on the one or more severity scores and thecompatibility profile. At block 620, the skin care management system 530updates the compatibility profile based on the additional ingredient. Atblock 622, the skin care management system 530 determines if there areadditional secondary skin conditions. If the skin care management system530 determines there are additional secondary skin conditions, (“YES” atblock 622), the skin care management system 530 selects an additionalingredient based on the one or more severity scores and thecompatibility profile. In some embodiments, the number of additionalingredients is at least three. In one embodiment, the number ofadditional ingredients is three. At block 624, if the skin caremanagement system 530 determined there are no additional secondary skinconditions, (“NO” at block 622), the skin care management system 530displays one or more cosmetic formulations to the user. At block 636,the skin care management system 530 receives from the input/outputdevice 510 a selection of one or more cosmetic formulations from theuser. At block 638, the skin care management system 530 regulates thecosmetic dispensing system 520 to dispense and/or mix the selectedingredients to form the selected cosmetic formulation.

FIG. 7 is a flowchart of a method 700 of managing a skin care system500. At block 702, the skin care management system 530 receives from theinput/output device 510 one or more digital images corresponding to skininformation from a user. At block 704, the skin care management system530 pre-processes the one or more digital images to extract one or morefeatures from the one or more images. At block 706, the skin caremanagement system 530 analyzes the one or more extracted features toproduce a recognized pattern corresponding to one or more skinconditions within the digital image. At block 708, the skin caremanagement system 530 determines one or more skin conditions based onthe recognized pattern. At block 710, the skin care management system530 determines one or more severity scores based on the one or more skinconditions. At block 712, the skin care management system 530 determinesa primary skin condition based on the one or more severity scores. Atblock 714, the skin care management system 530 selects a firstingredient based on the severity scores. At block 716, the skin caremanagement system 530 generates a compatibility profile based on thefirst ingredient. At block 718, the skin care management system 530determines one or more secondary skin conditions for treatment based onthe one or more severity scores. At block 720, the skin care managementsystem 530 selects an additional ingredient based on the one or moreseverity scores and compatibility profile. At block 722, the skin caremanagement system 530 updates the compatibility profile based on theadditional ingredient. At block 724, the skin care management system 530determines if there are additional secondary skin conditions. If theskin care management system 530 determines there are additionalsecondary skin conditions, (“YES” at block 724), the skin caremanagement system 530 selects an additional ingredient based on the oneor more severity scores and the compatibility profile. At block 726, ifthe skin care management system 530 determined there are no additionalskin conditions targeted for treatment, (“NO” at block 724), the skincare management system 530 displays one or more cosmetic formulations tothe user. At block 728, the skin care management system 530 receivesfrom the input/output device 510 a selection of one or more cosmeticformulations from the user. At block 730, the skin care managementsystem 530 regulates the cosmetic dispensing system 520 to dispenseand/or mix the selected ingredients to form the selected cosmeticformulation.

FIG. 8 is a flowchart of a method 800 of managing a skin care system500. At block 802, the skin care management system 530 receives from theinput/output device 510 one or more measurements from a sensor (e.g.,magnetic, optical, non-optical, optoelectronic, electronic, andcombinations thereof) corresponding to skin information from a user. Atblock 804, the skin care management system 530 determines one or moreskin conditions based on the one or more measurements. At block 806, theskin care management system 530 determines one or more severity scoresbased on the one or more skin conditions. At block 808, the skin caremanagement system 530 determines a primary skin condition based on theone or more severity scores. At block 810, the skin care managementsystem 530 selects a first ingredient based on the one or more severityscores. At block 812, the skin care management system 530 generates acompatibility profile based on the first ingredient. At block 814, theskin care management system 530 determines one or more secondary skinconditions based on the one or more severity scores. At block 816, theskin care management system 530 selects an additional ingredient basedon the one or more severity scores and the compatibility profile. Atblock 818, the skin care management system 530 updates the compatibilityprofile based on the additional ingredient. At block 820, the skin caremanagement system 530 determines if there are additional secondary skinconditions. If the skin care management system 530 determines there areadditional secondary skin conditions, (“YES” at block 820), the skincare management system 530 selects an additional ingredient based on theone or more severity scores and the compatibility profile. At block 822,if the skin care management system 530 determined there are noadditional skin conditions targeted for treatment, (“NO” at block 820),the skin care management system 530 displays one or more cosmeticformulations to the user. At block 824, the skin care management system530 receives from the input/output device 510 a selection of one or morecosmetic formulations from the user. At block 826, the skin caremanagement system 530 regulates the cosmetic dispensing system 520 todispense and/or mix the selected ingredients to form the selectedcosmetic formulation.

FIG. 9 is a flowchart of a method 900 of managing a skin care system500. At block 902, the skin care management system 530 generates a userinterface including one or more visual representations of a categoricalskin condition, each of the visual representations corresponding to aseverity score for the categorical skin condition. At block 904, theskin care management system 530 generates one or more severity scoresresponsive to one or more inputs indicative of a user-selectedcategorical skin condition. At block 906, the skin care managementsystem 530 generates a skin care regimen information including acosmetic formulation based on one or more inputs associated with aseverity score and one or more inputs indicative of a compatibilityinformation associated with one or more cosmetic formulations. At block908, the skin care management system 530 generates control commands fordispensing the cosmetic formulation based on the one or more inputsindicative of the compatibility information associated with the cosmeticformulation. At block 910, the skin care management system 530 generatescontrol commands for mixing the cosmetic formulation based on the one ormore inputs indicative of the compatibility information associated withthe cosmetic formulation.

Dispensing System

FIG. 10 shows a cosmetic dispensing system 100, as shown in FIG. 1,according to an embodiment with the hinged lid 102 removed. FIG. 10shows mixing module 103. Mixing module 103 serves to mix the boostercompositions and base composition dispensed to the receiving receptacle109. The mixing module 103 includes a mixing side 1001 where a carrier1003 that holds the receiving receptacle 109 and a balancing side 1005which includes a counterweight 1007. The carrier 1003 is configured toreceive the receiving receptacle 109, which has been filled by thedispensing module 101. To mix the formulation, the receiving receptacle109 is filled with the dispensing module 101 and removed from thereceiving portion and inserted into the carrier 1003. The receivingreceptacle 109 is sized to fit within the carrier 1003 in a manner thatprevents disengagement during mixing. A rotating support 1009 extendsacross the balancing side 1005 and the mixing side 1001. A drive motor(not shown) serves to drive the rotating support 1009 via a drive shaftin circular path about axis 1013. On the mixing side, the carrier 1003is a rotating carrier which is driven by way of a flexible drive belt1015 that is driven by a drive motor (not shown) to rotate the receivingreceptacle 109 in carrier 1003 about an axis 1017 that is disposed at anangle with respect to axis 1013. The drive motor for rotating therotating support 1009 and the carrier 1003 are the same and areconnected via the flexible drive belt 1015.

FIG. 11 show detailed views of the carousel 107 and dispensing dosingreceptacles 105 of dispensing module 101 with the hinged lid 102 and theouter housing 104 removed. The carousel 107 includes slots 1100 forreceiving the dispensing dosing receptacles 105. Additionally, a centerportion 1103 attaches the interior section of the carousel 107 to amotor (not shown). The motor drives the carousel 107 in a circular pathabout axis 1105. The carousel 107 is driven so that the individualdispensing dosing receptacles 105 are aligned such that ingredientscontained therein may be dispensed into the receiving receptacle 109.The carousel 107 is repeatedly driven with alignments of the dispensingdosing receptacles 105 and repeated dispensing until the formulation,including the base composition and booster compositions, is dispensedinto the receiving receptacle 109.

FIG. 12 show the dispensing module 105 including the dispensing actuator1201. The dispensing detailed views of the carousel 107 and dispensingdosing receptacles 105 of dispensing module 101 with the hinged lid 102and the outer housing 104 removed. FIG. 12 shows dispensing actuator1201, which includes the dispensing motor 1203 and dispensing plunger1205. The dispensing motor 1203 receives a signal from the CPU when thecarousel 107 moves a dispensing dosing receptacle 105 into thedispensing region 1207. The dispensing motor 1203 activates to rotatetransmitting spindle 1209 which causes rotation of receiving spindle1211 through coupling by transfer belt 1213. Rotation of receivingspindle 1211 results in an up or down motion of plunger 1205. Thedispensing plunger 1205 extends down into the dispensing receptacles 105to result in a dispensing of the base composition or the boostercomposition into the receiving receptacle. The CPU is configured todetect when a target volume is reached with a closed loop using a loadcell. The load cell (not shown) is disposed under the receivingreceptacle. The load cell measures the actual volume dispensed byweighing the container holder being filled and causes a signal to betransmitted to the dispensing motor to cause the plunger 1205 to retractas soon as volume is reached. The formulation dispensed is a formulationcorresponding to a compatibility profile and consumer skin conditionswhich, when mixed, forms a stable composition having efficaciousconcentrations of active ingredients.

Additionally the dispensing system 100 according to the presentdisclosure includes a drip-management system. The drip-management systemincludes a plurality of removable trays to accumulate rouge droplets,and an air-blowing system used to blow excess material from the tips ofthe dosing receptacles onto a removable pad.

FIG. 13 shows a block diagram of the hardware included in the apparatus.A central processing unit (CPU) 1310 provides primary control over theseparate circuitry components included in the apparatus, such as thecarousel motor control circuitry 1320, the NFC Interface 1330, thedispenser control circuitry 1340 (which includes the dispensing motorcontrol circuitry and the inductive sensor circuitry), the load cellconditioning circuitry 1350, the mixer control circuitry 1360. The CPU1310 also controls an optional input/output device (such as a keyboardor mouse), a memory 1380, the wireless communication interface circuitry1374, a universal serial bus (USB) controller 1376, a LED driver 1378,and a display module 1380.

In an embodiment, any of the CPU 1310 or other components shown in FIG.13 may be substituted with alternative circuitry elements. Examples ofcircuitry includes memory that, for example, stores instructions orinformation. Non-limiting examples of memory include volatile memory(e.g., Random Access Memory (RAM), Dynamic Random Access Memory (DRAM),or the like), non-volatile memory (e.g., Read-Only Memory (ROM),Electrically Erasable Program-mable Read-Only Memory (EEPROM), CompactDisc Read-Only Memory (CD-ROM), or the like), persistent memory, or thelike. Further non-limiting examples of memory include ErasableProgrammable Read-Only Memory (EPROM), flash memory, or the like. In anembodiment, memory is coupled to, for example, one or more computingdevices by one or more instructions, information, or power buses.

In an embodiment, circuitry includes one or more computer-readable mediadrives, interface sockets, Universal Serial Bus (USB) ports, memory cardslots, or the like, and one or more in-put/output components such as,for example, a graphical user interface, a display, a keyboard, akeypad, a trackball, a joystick, a touch-screen, a mouse, a switch, adial, or the like, and any other peripheral device. In an embodiment, amodule includes one or more user input/output components that areoperably coupled to at least one computing device configured to control(electrical, electromechanical, software-implemented,firmware-implemented, or other control, or combinations thereof) atleast one parameter associated with, for example, determining one ormore tissue thermal properties responsive to detected shifts in turn-ONvoltage.

In an embodiment, circuitry includes a computer-readable media drive ormemory slot that is configured to accept signal-bearing medium (e.g.,computer-readable memory media, computer-readable recording media, orthe like). In an embodiment, a program for causing a system to executeany of the disclosed methods can be stored on, for example, acomputer-readable re-cording medium, a signal-bearing medium, or thelike. Non-limiting examples of signal-bearing media include a recordabletype medium such as a magnetic tape, floppy disk, a hard disk drive, aCompact Disc (CD), a Digital Video Disk (DVD), Blu-Ray Disc, a digitaltape, a computer memory, or the like, as well as transmission typemedium such as a digital or an analog communication medium (e.g., afiber optic cable, a waveguide, a wired communications link, a wirelesscommunication link (e.g., receiver, transmitter, transceiver,transmission logic, reception logic, etc.). Further non-limitingexamples of signal-bearing media include, but are not limited to,DVD-ROM, DVD-RAM, DVD+RW, DVD-RW, DVD-R, DVD+R, CD-ROM, Super Audio CD,CD-R, CD+R, CD+RW, CD-RW, Video Compact Discs, Super Video Discs, flashmemory, magnetic tape, magneto-optic disk, MINIDISC, non-volatile memorycard, EEPROM, optical disk, optical storage, RAM, ROM, system memory,web server, or the like.

In an embodiment, circuitry includes acoustic transducers,electroacoustic transducers, electro-chemical transducers,electromagnetic transducers, electromechanical transducers,electrostatic transducers, photoelectric transducers, radioacoustictransducers, thermoelectric transducers, or ultrasonic transducers.

In an embodiment, circuitry includes electrical circuitry operablycoupled with a transducer (e.g., an actuator, a motor, a piezoelectriccrystal, a Micro Electro Mechanical System (MEMS), etc.) In anembodiment, circuitry includes electrical circuitry having at least onediscrete electrical circuit, electrical circuitry having at least oneintegrated circuit, or electrical circuitry having at least oneapplication specific integrated circuit. In an embodiment, circuitryincludes electrical circuitry forming a general purpose computing deviceconfigured by a computer pro-gram (e.g., a general purpose computerconfigured by a computer program which at least partially carries outprocesses and/or devices described herein, or a microprocessorconfigured by a computer program which at least partially carries outprocesses and/or devices described here-in), electrical circuitryforming a memory device (e.g., forms of memory (e.g., random access,flash, read only, etc.)), electrical circuitry forming a communicationsdevice (e.g., a modem, communications switch, optical-electricalequipment, etc.), and/or any non-electrical analog thereto, such asoptical or other analogs.

FIG. 14 shows a skin care system 1400 which implements the cosmeticdispensing system 100 described above. As shown in FIG. 14, the system1400 includes at least the cosmetic dispensing system 100, aninformation processing apparatus 1410, and a printer 1420. Optionally,the system may further include one or more external server devices orinformation processing apparatuses 1430 which are implemented as part ofa cloud-computing environment. Furthermore, the system may optionallyinclude inventory 1440 which is an inventory for booster compositionsand base compositions to be inserted into the cosmetic dispensing system100.

The information processing apparatus 1410 may be a personal computer(PC), a laptop computer, a PDA (Personal Digital Assistants), a smartphone, a tablet device, a UMPC (Ultra Mobile Personal Computer), anet-book, or a notebook type personal computer. In the below examples,the information processing apparatus 1410 is assumed to be a tabletdevice, such as an Apple iPad.

The printer 1420 may be any type of printing device or image formingdevice as understood in the art which has the capability of printing alabel. In the below examples, the printing device is assumed to be alabel printer, such as the Wireless Brother PTP750 W.

Each of the information processing apparatus 1410 and the printer 1420are capable of performing wireless communication with the cosmeticdispensing system 100 by way of the Bluetooth interface on the cosmeticdispensing system 100. However, each of the information processingapparatus 1410 and the printer 1420 are also capable of having a wiredconnection to the cosmetic dispensing system 100 by way of the USBinterface on the cosmetic dispensing system 100. Additionally, eachdevice, including the cosmetic dispensing system 100, may communicatewith each other and the external one or more devices through an internetconnection via an 802.11 wireless connection to a wireless internetaccess point, or a physical connection to the internet access point,such as through an Ethernet interface. Each of the informationprocessing apparatus 1410 and the printer 1420 are capable of performingwireless communication with each other through a Bluetooth connection orother wireless means as well.

The information processing apparatus 1410 is configured to receiveinformation about a user for use in generating a recipe that will beused by the cosmetic dispensing system 100 to dispense a compositioninto the output container. The information processing apparatus 1410 maybe operated by a skin care professional at the location, such asdermatologist office, where the dispensed composition is dispensed andprovided to the customer user. However, the information processingapparatus 1410 can also be operated directly by the customer user.

In one embodiment, a process or algorithm performed by the circuitry ofan information processing apparatus for selecting the ingredients anddetermining the compatibility profile.

In one embodiment, according to the present disclosure, the skin carecomposition is dispensed and/or mixed with the cosmetic dispensingsystem 100. The system includes a base composition dispensing systemcomprising an aqueous alcohol composition and an aqueous emulsion. Thesystem further includes a booster composition dispensing systemcomprising each of the following booster compositions: a first gradeexfoliating agent; a second grade exfoliating agent; a first gradewhitening agent; a second grade whitening agent; a first gradeanti-aging agent; and a second grade anti-aging agent. The basecomposition dispensing system is arranged and disposed to provide one ofthe base compositions and the booster composition dispensing systemarranged and disposed to provide at least two of the boostercompositions.

The following examples are intended to further illustrate the presentdisclosure. They are not intended to limit the disclosure in any way.Unless otherwise indicated, all parts are by weight.

EXAMPLES

TABLE 2 includes booster and base compositions utilized in examples andcomparative examples.

TABLE 2 Booster or Base Booster/Base Composition (% Code in Formulation)Category 1 6.7% glycolic acid, 3.3% lactic Second Grade Exfoliationacid, 1.7% sodium phytate Agent 2 6% 4-(2-hydroxyethyl)-1- First GradeExfoliation piperazineethanesulfonic acid, Agent 5.45% hydroxyethyl urea3 3% tranexamic acid, 1.25% urea Second Grade Whitening Agent 4 3%niacinamide, 1% kojic Acid Second Grade Whitening Agent 5 0.1% licoriceextract, 0.0025% First Grade Whitening mulberry extract Agent 6 3.5%C-beta-D-xylopyranoside- First Grade Anti-Aging 2-hydroxypropane Agent 70.1-1.0% retinol Second Grade Anti-Aging Agent 8 0.5% phenylethylresorcinol Second Grade Whitening Agent B hydroalcoholic base Base Caqueous Emulsion base Base

Examples and comparative examples below are provided by the cosmeticdispending system as shown and described above. TABLE 3 includes thecomposition of Base B, the hydroalcoholic base, according to anembodiment of the disclosure.

TABLE 3 Base B: Hydroalcoholic Base Composition Concentration (% by Namewt of base composition) Denatured Alcohol 35% Water 65% Total 100% 

TABLE 4 includes the composition of Base C, the aqueous emulsion base,according to an embodiment of the disclosure.

TABLE 4 Base C: Aqueous Emulsion Base Composition Concentration (% by wtof base Name composition) disodium EDTA 0.1 fatty compound 2 polymer 10.15 polymer 2 0.5 polymer 3 0.6 preservative 0.7 silicon 2 solvent 1 3solvent 2 4 solvent 3 3 solvent 4 0.3 surfactant 0.5 vitamin 0.5 water82.65

TABLE 5 includes inventive Examples of formulations including a first,second, third and fourth ingredient having abase composition and threebooster compositions.

TABLE 5 EXAMPLE 1 2 3 Reference B (1 + 4 + 5) B (1 + 4 + 6) B (1 + 5 +6) Code Base Hydro-alcoholic Hydro-alcoholic Hydro-alcoholic ActiveExfoliators Exfoliators Exfoliators Levels 6.7% Glycolic 6.7% Glycolic6.7% Glycolic Acid Acid Acid 3.3% Lactic Acid 3.3% Lactic Acid 3.3%Lactic Acid 1.7% Sodium 1.7% Sodium 1.7% Sodium Phytate Phytate PhytateLightening Agents Lightening Agents Lightening Agents 3% Niacinamide 3%Niacinamide 0.1% Licorice 1% Kojic Acid 1% Kojic Acid Extract 0.1%Licorice 0.0025% Mulberry Extract Extract 0.0025% Mulberry ExtractAnti-Aging Agents Anti-Aging Agents 3.5% MA Pro-Xylane 3.5% MAPro-Xylane pH 3.73 3.53 3.71 Stable YES YES YES

TABLE 6 includes inventive Examples of formulations including a first,second, third and fourth ingredient having abase composition and threebooster compositions.

TABLE 6 EXAMPLE 4 5 6 Reference B (2 + 4 + 5) B (2 + 4 + 6) B (2 + 5 +6) Code Base Hydro-alcoholic Hydro-alcoholic Hydro-alcoholic ActiveExfoliators Exfoliators Exfoliators Levels 6% HEPES 6% HEPES 6% HEPES5.45% Hydroxyethyl Urea 5.45% Hydroxyethyl Urea 5.45% Hydroxyethyl UreaLightening Agent Lightening Agent Lightening Agent 3% Niacinamide 3%Niacinamide 0.1% Licorice Extract 1% KojicAcid 1% Kojic Acid 0.0025%Mulberry Extract 0.1% Licorice Extract 0.0025% Mulberry ExtractAnti-Aging Agents Anti-Aging Agents 3.5% MA Pro-Xylane 3.5% MAPro-Xylane pH 5.56 5.27 5.66 Stable YES YES YES

TABLE 7 includes inventive Examples of formulations including a first,second, third and fourth ingredient having abase composition and threebooster compositions.

TABLE 7 EXAMPLE 7 8 9 Reference C (2 + 4 + 5) C (2 + 5 + 6) C (2 + 4 +6) Code Base O/W Emulsion O/W Emulsion O/W Emulsion Active ExfoliatorsExfoliators Exfoliators Levels 6% HEPES 6% HEPES 6% HEPES 5.45%Hydroxyethyl Urea 5.45% Hydroxyethyl Urea 5.45% Hydroxyethyl UreaLightening Agent Lightening Agent Lightening Agent 3% Niacinamide 0.1%Licorice Extract 3% Niacinamide 1% Kojic Acid 0.0025% Mulberry Extract1% Kojic Acid 0.1% Licorice Extract 0.0025% Mulberry Extract Anti-AgingAgent Anti-Aging Agent 3.5% MA Pro-Xylane 3.5% MA Pro-Xylane pH 5.435.43 5.44 Stable YES YES YES

TABLE 8 includes inventive Examples of formulations including a first,second, third and fourth ingredient having abase composition and threebooster compositions.

TABLE 8 EXAMPLE 10 11 12 Reference C (2 + 4 + 8) C (2 + 5 + 8) C (2 +6 + 8) Code Base O/W Emulsion O/W Emulsion O/W Emulsion ActiveExfoliators Exfoliators Exfoliators Levels 6% HEPES 6% HEPES 6% HEPES5.45% Hydroxyethyl Urea 5.45% Hydroxyethyl Urea 5.45% Hydroxyethyl UreaLightening Agent Lightening Agent Lightening Agent 0.5% Symwhite 0.5%Symwhite 0.5% Symwhite 3% Niacinamide 0.1% Licorice Extract 1% KojicAcid 0.0025% Mulberry Extract Anti-Aging Agent 3.5% MA Pro-Xylane pH5.53 5.59 5.59 Stable Yes Yes Yes

TABLE 9 includes inventive Examples of formulations including a first,second, third and fourth ingredient having abase composition and threebooster compositions.

TABLE 9 EXAMPLE 13-16 17-20 21-24 Reference Code C (4 + 5 + 7) C (4 +6 + 7) C (5 + 6 + 7) Base Aqueous Emulsion Aqueous Emulsion AqueousEmulsion Active Levels Lightening Agent Lightening Agent LighteningAgent 3% Niacinamide 3% Niacinamide 0.1% Licorice Extract 1% Kojic Acid1% Kojic Acid 0.0025% Mulberry Extract 0.1% Licorice Extract 0.0025%Mulberry Extract Anti-Aging Agent Anti-Aging Agent Anti-Aging AgentRetinol 3.5% MA Pro-Xylane 3.5% MA Pro-Xylane Retinol Retinol pH 5.615.52 5.37 Retinol 0.1% Yes Yes Yes Stability (Ex. 13, 17 and 21) Retinol0.3% Yes Yes Yes Stability (Ex. 14, 18 and 22) Retinol 0.5% Yes Yes YesStability (Ex. 15, 19 and 23) Retinol 1.0% Yes Yes Yes Stability (Ex.16, 20 and 24)

TABLE 10 includes inventive Examples of formulations including a first,second, third and fourth ingredient having abase composition and threebooster compositions.

TABLE 10 EXAMPLE 25-28 29-32 33-36 Reference Code C (4 + 7 + 8) C (5 +7 + 8) C (6 + 7 + 8) Base O/W Emulsion O/W Emulsion O/W Emulsion ActiveLevels Lightening Agents Lightening Agent Lightening Agent 0.5% Symwhite0.5% Symwhite 0.5% Symwhite 3% Niacinamide 0.1% Licorice 1% Kojic AcidExtract 0.0025% Mulberry Extract Anti-Aging Agent Anti-Aging AgentAnti-Aging Agent Retinol Retinol 3.5% MA Pro-Xylane Retinol pH 5.4 5.125.44 Retinol 0.1% Yes Yes Yes Stability (Ex. 25, 29 and 33) Retinol 0.3%Yes Yes Yes Stability (Ex. 26, 30 and 34) Retinol 0.5% Yes Yes YesStability (Ex. 27, 31 and 35) Retinol 1.0% Yes Yes Yes Stability (Ex.28, 32 and 36)

TABLE 11 includes inventive Examples of formulations including a first,second, third and fourth ingredient having abase composition and threebooster compositions.

TABLE 11 Example 37 38 39 B (2 + 3 + 4) B (2 + 3 + 5) B (2 + 3 + 6) BaseHydro-alcoholic Hydro-alcoholic Hydro-alcoholic Active LevelsExfoliators Exfoliators Exfoliators 6% HEPES 6% HEPES 6% HEPES 5.45%Hydroxyethyl Urea 5.45% Hydroxyethyl Urea 5.45% Hydroxyethyl UreaLightening Agents Lightening Agents Lightening Agents 3% Tranexamic acid3% Tranexamic acid 3% Tranexamic acid 1.25% Urea 1.25% Urea 1.25% Urea3% Niacinamide 0.1% Licorice Extract 1% Kojic Acid 0.0025% MulberryExtract Anti-Aging Agents 3.5% MA Pro-Xylane pH 6.18 6.19 6.28 NoRetinol Yes Yes Yes Stability

TABLE 12 includes inventive Examples of formulations including a first,second, third and fourth ingredient having abase composition and threebooster compositions.

TABLE 12 Example 40 41 42 C (3 + 4 + 7) C (3 + 5 + 7) C (3 + 6 + 7) BaseAqueous Emulsion Aqueous Emulsion Aqueous Emulsion Active LighteningAgents Lightening Agent Lightening Agent Levels 3% Tranexamic 3%Tranexamic acid 3% Tranexamic acid 1.25% Urea acid 1.25% Urea 0.1%Licorice 1.25% Urea 3% Niacinamide Extract 1% Kojic Acid 0.0025%Mulberry Extract Anti-Aging Agent Anti-Aging Agent Anti-Aging AgentRetinol Retinol 3.5% MA Pro-Xylane Retinol pH 6.45 6.93 6.65 Retinol 0.1Yes Yes Yes Retinol 0.5 Yes Yes Yes Retinol 0.3 Yes Yes Yes Retinol 1.0Yes Yes Yes

TABLE 13 includes comparative Examples of formulations including afirst, second, third and fourth ingredient having a base composition andthree booster compositions.

TABLE 13 COMPARATIVE EXAMPLE C1 C2 C3 Base B B B Booster 1 + 4 + 7 1 +5 + 7 2 + 4 + 7 Stable No No No

TABLE 14 includes comparative Examples of formulations including afirst, second, third and fourth ingredient having a base composition andthree booster compositions.

TABLE 14 COMPARATIVE EXAMPLE C4 C5 C6 Base B B B Booster 1 + 5 + 7 1 +6 + 7 1 + 3 + 7 Stable No No No

TABLE 15 includes comparative Examples of formulations including afirst, second, third and fourth ingredient having a base composition andthree booster compositions.

TABLE 15 COMPARATIVE EXAMPLE C7 C8 C9 Base B B B Booster 1 + 3 + 5 1 +3 + 6 2 + 5 + 7 Stable No No No

TABLE 16 includes comparative Examples of formulations including afirst, second, third and fourth ingredient having a base composition andthree booster compositions.

TABLE 16 COMPARATIVE EXAMPLE C10 C11 C12 Base C C C Booster 1 + 4 + 51 + 5 + 6 1 + 4 + 6 Stable No No No

TABLE 17 includes comparative Examples of formulations including afirst, second, third and fourth ingredient having a base composition andthree booster compositions.

TABLE 17 COMPARATIVE EXAMPLE C13 C14 C15 Base C C C Booster 1 + 4 + 81 + 5 + 8 1 + 6 + 8 Stable No No No

TABLE 18 includes comparative Examples of formulations including afirst, second, third and fourth ingredient having a base composition andthree booster compositions.

TABLE 18 COMPARATIVE EXAMPLE C16 C17 C18 C19 Base C C C C Booster 1 +5 + 7 1 + 4 + 7 1 + 6 + 7 1 + 7 + 8 Stable No No No No

While the disclosure has been described with reference to a preferredembodiment, it will be understood by those skilled in the art thatvarious changes may be made and equivalents may be substituted forelements thereof without departing from the scope of the disclosure. Inaddition, many modifications may be made to adapt a particular situationor material to the teachings of the disclosure without departing fromthe essential scope thereof. While various aspects and embodiments havebeen disclosed herein, other aspects and embodiments will be apparent tothose skilled in the art. The various aspects and embodiments disclosedherein are for purposes of illustration and are not intended to belimiting, with the true scope and spirit being indicated by thefollowing claims.

What is claimed is:
 1. A method for managing a skin care systemcomprising: generating a user interface including one or more visualrepresentations of a categorical skin condition, each of the visualrepresentations corresponding to a severity score for the categoricalskin condition; generating one or more severity scores responsive to oneor more inputs indicative of a user-selected categorical skin condition;and generating skin-care-regimen information including cosmeticformulation information based on one or more inputs associated with aseverity score and one or more inputs indicative of compatibilityinformation associated with one or more cosmetic formulations.
 2. Themethod of claim 1, wherein generating the skin-care-regimen informationincluding cosmetic formulation information includes generating acosmetic formulation recipe having three or more ingredients.
 3. Themethod of claim 2, wherein generating the skin-care-regimen informationincluding cosmetic formulation information includes generating acosmetic formulation recipe having one or more base compositions and twoor more booster compositions.
 4. The method of claim 1, furthercomprising generating a user interface including one or more visualrepresentations of the one or more cosmetic formulations.
 5. The methodof claim 1, further comprising generating control commands fordispensing the cosmetic formulation based on the one or more inputsindicative of the compatibility information associated with the cosmeticformulation.
 6. The method of claim 5, further comprising generatingcontrol commands for mixing the cosmetic formulation based on the one ormore inputs indicative of the compatibility information associated withthe cosmetic formulation.
 7. The method of claim 1, further comprisinggenerating control commands for dispensing the cosmetic formulationbased on the one or more inputs indicative of the compatibilityinformation associated with the cosmetic formulation and responsive toone or more inputs indicative of a user-selected cosmetic formulation.8. The method of claim 7, further comprising generating control commandsfor mixing the cosmetic formulation based on the one or more inputsindicative of the compatibility information associated with the cosmeticformulation.
 9. The method of claim 1, further comprising communicatingwith a medical professional over a distributed network.
 10. The methodof claim 9, wherein the communicating with the medical professional overa distributed network includes exchanging encrypted and anonymized data.11. The method of claim 1, wherein generating the user interfaceincluding one or more visual representations of a categorical skincondition includes generating a user interface comprising aquestionnaire.
 12. The method of claim 1, wherein the skin care regimenincludes the compatibility profile.